Farrell Michael J.
Farrell Michael J., DIR, reported a transaction classified as grant at ZIMMER BIOMET HOLDINGS, INC. involving 875.350000 shares for an estimated $0.00. Reported holdings after the transaction were 19173.940000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 22, 2026
- Filing date
- May 27, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ZBH price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001485164-26-000006 Phantom Stock Units
- Transaction date
- May 22, 2026 Filed May 27, 2026, 08:14 PM · 5d delay
- Shares
- 875.35 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 19,173.94 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
- F2
The Conversion or Exercise Price of Derivative Security is 1-for-1.
- F3
Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
- F4
Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
- F5
The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three y…
- F6
Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
0 other transactions
0 recent txs